Table 2.
Behavioral and clinical characteristics reported at the assessment of cure by HIV status*
| HIV-seropositive | HIV-seronegative | P-value** | |
|---|---|---|---|
| N=282 | N=288 | ||
| Sexual activity in the past week | 141 (50) | 168 (58) | 0.08 |
| Number of sexual episodes in the past week | |||
| 1 sex act | 65 (23) | 65 (23) | 0.5 |
| 2 or more sex acts | 76 (27) | 103 (36) | 0.04 |
| Number of partners in the past week | |||
| 1 partner | 112 (40) | 124 (43) | 0.2 |
| 2 or more partners | 29 (10) | 44 (15) | 0.09 |
| Unprotected sex in the past week1 | 43 (15) | 64 (22) | 0.06 |
| Vaginal washing in the past week | 268 (95) | 240 (83) | 0.001 |
| Bacterial vaginoisis2 | 117 (42) | 120 (42) | 1.00 |
| Clue cells detected on wet prep | 113 (40) | 103 (36) | 0.3 |
| Yeast present on wet prep | 38 (14) | 24 (8) | 0.05 |
| Gonorrhea | 9 (3) | 11 (4) | 0.7 |
| Cervicitis3 | 5 (2) | 30 (10) | 0.002 |
N (%) presented.
*
N represents the number of TV infections contributed by 360 unique participants. Eleven participants contributed infections while HIV-seronegative and HIV-seropositive.
**
P-value generated from models using generalized estimating equations with a logit link to account for multiple infections per participant.
1
Unprotected sex vs. 100% condom use or no sex.
2
Nugent score 7–10.
3
Defined as the presence of an average of =30 polymorphonuclear leukocytes per high-power field on microscopic examination of Gram-stained cervical secretions (original magnification X100).